Amplia Therapeutics Ltd.ASX: ATX

Inhibition of FAK by AMP945 in Phase 1 Clinical Trial

Nov 17, 2021 at 2:46 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment